Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-060659
Filing Date
2024-05-13
Accepted
2024-05-13 17:08:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2413608d2_defa14a.htm DEFA14A 16780
2 GRAPHIC tm2413608d2_def14aimg001.jpg GRAPHIC 15390
  Complete submission text file 0001104659-24-060659.txt   39169
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40363 | Film No.: 24940224
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)